{"title":"Cathepsin B promotes optic nerve axonal regeneration.","authors":"Si Zhang, Hui Zhu, Guopei Li, Min Zhu","doi":"10.1097/WNR.0000000000002148","DOIUrl":null,"url":null,"abstract":"<p><p>This study explored the role of cathepsin B (CTSB) in optic nerve regeneration. Sprague-Dawley rats were utilized for optic nerve crush and long-range crush injury model. Gene and protein expression changes were analyzed via reverse transcription quantitative polymerase chain reaction and western blot. Primary cortical neurons and BV2 cells were cultured to assess CTSB's effects on neuronal outgrowth and microglial activity. Local CTSB administration degraded chondroitin sulfate proteoglycans (CSPGs), promoting axonal growth in-vivo. In-vitro, CTSB neutralized CSPG-mediated inhibition of neuronal growth. Quantitative proteomics revealed elevated microglial marker proteins in the regenerative environment. Activation of signal transducer and activator of transcription 3 (STAT3) and signal transducer and activator of transcription 6 (STAT6) pathways in BV2 cells increased CTSB secretion. These findings suggest that postinjury regenerative microenvironment reconstruction is associated with upregulated CTSB, which degrades CSPGs to facilitate axonal growth. Microglia-derived CTSB, regulated by STAT3/STAT6 signaling, may play a key role in this process. Modulating CTSB expression could thus be a therapeutic strategy to enhance optic nerve regeneration by modifying the injury microenvironment.</p>","PeriodicalId":19213,"journal":{"name":"Neuroreport","volume":"36 6","pages":"279-289"},"PeriodicalIF":1.6000,"publicationDate":"2025-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11949221/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuroreport","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/WNR.0000000000002148","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/26 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
This study explored the role of cathepsin B (CTSB) in optic nerve regeneration. Sprague-Dawley rats were utilized for optic nerve crush and long-range crush injury model. Gene and protein expression changes were analyzed via reverse transcription quantitative polymerase chain reaction and western blot. Primary cortical neurons and BV2 cells were cultured to assess CTSB's effects on neuronal outgrowth and microglial activity. Local CTSB administration degraded chondroitin sulfate proteoglycans (CSPGs), promoting axonal growth in-vivo. In-vitro, CTSB neutralized CSPG-mediated inhibition of neuronal growth. Quantitative proteomics revealed elevated microglial marker proteins in the regenerative environment. Activation of signal transducer and activator of transcription 3 (STAT3) and signal transducer and activator of transcription 6 (STAT6) pathways in BV2 cells increased CTSB secretion. These findings suggest that postinjury regenerative microenvironment reconstruction is associated with upregulated CTSB, which degrades CSPGs to facilitate axonal growth. Microglia-derived CTSB, regulated by STAT3/STAT6 signaling, may play a key role in this process. Modulating CTSB expression could thus be a therapeutic strategy to enhance optic nerve regeneration by modifying the injury microenvironment.
期刊介绍:
NeuroReport is a channel for rapid communication of new findings in neuroscience. It is a forum for the publication of short but complete reports of important studies that require very fast publication. Papers are accepted on the basis of the novelty of their finding, on their significance for neuroscience and on a clear need for rapid publication. Preliminary communications are not suitable for the Journal. Submitted articles undergo a preliminary review by the editor. Some articles may be returned to authors without further consideration. Those being considered for publication will undergo further assessment and peer-review by the editors and those invited to do so from a reviewer pool.
The core interest of the Journal is on studies that cast light on how the brain (and the whole of the nervous system) works.
We aim to give authors a decision on their submission within 2-5 weeks, and all accepted articles appear in the next issue to press.